ReShape Lifesciences
ReShape Lifesciences
RSLS
NASDAQ
0.64
USD
0.00%
About
ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy.
The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss.
Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 393.8K |
| Three Month Average Volume | 34.4M |
| High Low | |
| Fifty-Two Week High | 1.29 USD |
| Fifty-Two Week Low | 0.1414 USD |
| Fifty-Two Week High Date | 06 Sep 2023 |
| Fifty-Two Week Low Date | 14 Feb 2024 |
| Price and Volume | |
| Current Price | 0.161 USD |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | -16.31% |
| Thirteen Week Relative Price Change | -40.99% |
| Twenty-Six Week Relative Price Change | -15.80% |
| Fifty-Two Week Relative Price Change | -86.19% |
| Year-to-Date Relative Price Change | -45.55% |
| Price Change | |
| One Day Price Change | 0.19% |
| Thirteen Week Price Change | -36.84% |
| Twenty-Six Week Price Change | -7.42% |
| Five Day Price Change | -5.79% |
| Fifty-Two Week Price Change | -82.69% |
| Year-to-Date Price Change | -35.52% |
| Month-to-Date Price Change | -17.48% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 0.28405 USD |
| Book Value Per Share (Most Recent Quarter) | 0.10328 USD |
| Tangible Book Value Per Share (Last Fiscal Year) | 0.28405 USD |
| Tangible Book Value Per Share (Most Recent Quarter) | 0.10328 USD |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | -0.54453 USD |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 1.45688 USD |
| Revenue Per Share (Trailing Twelve Months) | 0.47659 USD |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | -99999.99 USD |
| Dividend Per Share (Trailing Twelve Months) | 0 USD |
| Dividend Per Share (5 Year) | -99999.99 USD |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | -1.91168 USD |
| Excluding Extraordinary Items (Trailing Twelve Months) | -1.29057 USD |
| Normalized (Last Fiscal Year) | -1.83049 USD |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | -1.91168 USD |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | -1.29057 USD |
| Including Extraordinary Items (Last Fiscal Year) | -1.91168 USD |
| Including Extraordinary Items (Trailing Twelve Months) | -1.29057 USD |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 0.19009 USD |
| Cash Per Share (Most Recent Quarter) | 0.03583 USD |
| Cash Flow Per Share (Last Fiscal Year) | -1.88582 USD |
| Cash Flow Per Share (Trailing Twelve Months) | -0.5302 USD |
| Free Cash Flow Per Share (Trailing Twelve Months) | -0.51332 USD |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | -230 |
| Cash Flow Revenue (Trailing Twelve Months) | -108 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | -111.32% |
| Pretax Margin (Last Fiscal Year) | -130.62% |
| Pretax Margin (5 Year) | -409.93% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 63.93% |
| Gross Margin (Trailing Twelve Months) | 67.47% |
| Gross Margin (5 Year) | 56.30% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | -177.26% |
| Operating Margin (Trailing Twelve Months) | -119.44% |
| Operating Margin (5 Year) | -408.63% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | -131.22% |
| Net Profit Margin (Trailing Twelve Months) | -112.11% |
| Net Profit Margin (5 Year) | -408.36% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -79.76% |
| Tangible Book Value (5 Year) | -12.66% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | -12.82% |
| Revenue Growth (3 Year) | -0.95% |
| Revenue Change (Trailing Twelve Months) | -23.00% |
| Revenue Per Share Growth | -71.06% |
| Revenue Growth (5 Year) | 76.14% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | -49.29% |
| Total Debt (5 Year) | -99,999.99% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | 94.12% |
| EPS Change (Trailing Twelve Months) | 97.97% |
| EPS Growth (3 Year) | -99,999.99% |
| EPS Growth (5 Year) | -99,999.99% |
| EBITDA | |
| EBITDA (5 Year) | -99,999.99% |
| EBITDA (5 Year Interim) | -99,999.99% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 1 |
| Price to Tangible Book (Most Recent Quarter) | 2 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
| Price to Free Cash Per Share (Trailing Twelve Months) | -100,000 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | -1,053,000 |
| Net Debt (Last Fiscal Year) | -4,459,000 |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 1 |
| Price to Sales (Trailing Twelve Months) | 1 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
| PE Normalized (Last Fiscal Year) | -100,000 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | -100,000 |
| PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% |
| Dividend Yield | -99,999.99% |
| Current Dividend Yield | 0.00% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 1 |
| Price to Book (Most Recent Quarter) | 2 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 0 |
| Long Term Debt to Equity (Most Recent Quarter) | 0 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | -99,999.99% |
| Payout Ratio (Trailing Twelve Months) | -99,999.99% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 2 |
| Quick Ratio (Most Recent Quarter) | 1 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 3 |
| Current Ratio (Most Recent Quarter) | 2 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | -17,003,000 |
| Free Cash Flow (Trailing Twelve Months) | -8,666,000 |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | -100,000 |
| Net Interest Coverage (Trailing Twelve Months) | -100,000 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 0 |
| Total Debt to Equity (Most Recent Quarter) | 0 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | -104.44% |
| Return on Assets (Trailing Twelve Months) | -98.88% |
| Return on Assets (5 Year) | -136.06% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -220.59% |
| Return on Equity (Trailing Twelve Months) | -184.59% |
| Return on Equity (5 Year) | -199.96% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | -215.93% |
| Return on Investment (Trailing Twelve Months) | -169.55% |
| Return on Investment (5 Year) | -194.32% |